InvestorsHub Logo
Followers 16
Posts 488
Boards Moderated 0
Alias Born 01/05/2013

Re: ihubmkasp post# 28390

Thursday, 07/31/2014 12:30:06 PM

Thursday, July 31, 2014 12:30:06 PM

Post# of 57991
First, thanks for the analysis. I am not concerned about the negative cash flow at this stage. This is essentially a start up that is in the beginning phases of its business model. I had a lot concerns about the initial negative cash flow of other start ups like AMZ* , NFL*, TLS* and look where they are now. Not to mention a lot of pharmachetical companies that bleed red over red every year. The real question is, can MELY execute their business plan. So far they have been executing ahead of schedule with a few positive surprises. It is too early in this game to conduct any cash flow analysis that will provide convincing evidence that MELY is not a going to be profitable in the long run. There simply are too many variables can change the numbers in a short period of time. Come back in a year and conduct the same analysis.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.